FI894321A0 - Terapeutiska aemnen. - Google Patents

Terapeutiska aemnen.

Info

Publication number
FI894321A0
FI894321A0 FI894321A FI894321A FI894321A0 FI 894321 A0 FI894321 A0 FI 894321A0 FI 894321 A FI894321 A FI 894321A FI 894321 A FI894321 A FI 894321A FI 894321 A0 FI894321 A0 FI 894321A0
Authority
FI
Finland
Prior art keywords
aemnen
therapeutic
therapeutic aemnen
Prior art date
Application number
FI894321A
Other languages
English (en)
Inventor
Roy Victor Davies
Michael Donald Brown
John Nicholas Holman
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of FI894321A0 publication Critical patent/FI894321A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/233Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/30Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
    • C07C233/33Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
FI894321A 1988-02-22 1989-09-13 Terapeutiska aemnen. FI894321A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888804016A GB8804016D0 (en) 1988-02-22 1988-02-22 Therapeutic agents
PCT/GB1989/000126 WO1989007593A1 (en) 1988-02-22 1989-02-09 Therapeutic agents

Publications (1)

Publication Number Publication Date
FI894321A0 true FI894321A0 (fi) 1989-09-13

Family

ID=10632104

Family Applications (1)

Application Number Title Priority Date Filing Date
FI894321A FI894321A0 (fi) 1988-02-22 1989-09-13 Terapeutiska aemnen.

Country Status (19)

Country Link
US (1) US4997840A (fi)
EP (1) EP0330340A1 (fi)
JP (1) JPH02503320A (fi)
KR (1) KR900700455A (fi)
CN (1) CN1049659A (fi)
AU (1) AU3187489A (fi)
DD (1) DD283609A5 (fi)
DK (1) DK497489A (fi)
FI (1) FI894321A0 (fi)
GB (1) GB8804016D0 (fi)
HU (1) HU891560D0 (fi)
IE (1) IE890293L (fi)
IL (1) IL89286A0 (fi)
NO (1) NO894187D0 (fi)
NZ (1) NZ228035A (fi)
PL (1) PL277819A1 (fi)
PT (1) PT89794A (fi)
WO (1) WO1989007593A1 (fi)
ZA (1) ZA89923B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8804016D0 (en) * 1988-02-22 1988-03-23 Boots Co Plc Therapeutic agents
SE9103745D0 (sv) * 1991-12-18 1991-12-18 Wikstroem Haakan Aryl-triflates and related compounds
AU5509099A (en) * 1998-08-03 2000-02-28 Basf Corporation Pyridinones for the treatment of sexual dysfunction
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
US6562838B2 (en) * 2001-01-26 2003-05-13 R. T. Alamo Ventures I, L.L.C. Treatment of cardiovascular disease with quinolinone enantiomers
US6458804B1 (en) 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3718653A (en) * 1970-02-26 1973-02-27 Int Minerals & Chem Corp Quinoyl alkanesulfonates and toluenesulfonates
US4192873A (en) * 1976-11-25 1980-03-11 Ciba-Geigy Corporation Anti-inflammatory 2-sulphonyl- (or -sulphinyl)-2'-aminoacetophenones
NZ193167A (en) * 1979-03-27 1984-08-24 Boots Co Plc Quinoline derivatives and pharmaceutical compositions
GB2085441B (en) * 1980-09-26 1984-10-17 Boots The Co Ltd Therapeutic agents
IE51542B1 (en) * 1980-09-26 1987-01-07 Boots Co Ltd Therapeutic agents
US4510290A (en) * 1982-01-11 1985-04-09 Ciba Geigy Corporation Acid-curable composition containing a masked curing catalyst, and a process for the curing thereof
DE3224512A1 (de) * 1982-07-01 1984-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazolderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel
FR2543140B1 (fr) * 1983-03-24 1985-06-21 Cortial Nouveaux acides flavone-carboxyliques-4', leur methode de preparation et leur application en therapeutique
FR2543550B1 (fr) * 1983-04-01 1985-08-09 Cortial Nouveaux derives de la tetrahydroxy-3', 4',5,7 flavone, leur methode de preparation et leur emploi therapeutique
DE3324115A1 (de) * 1983-07-05 1985-01-17 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazole, ihre herstellung und diese verbindungen enthaltende arzneimittel
PT79031B (en) * 1983-08-20 1986-08-22 Boots Co Plc Therapeutic agents
US4515796A (en) * 1983-09-08 1985-05-07 Eli Lilly And Company Certain naphthalenyl imidazo compounds and their pharmaceutical use
DE3346640A1 (de) * 1983-12-23 1985-07-04 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazolderivate, deren herstellung und diese verbindungen enthaltende arzneimittel
DE3578374D1 (de) * 1984-01-13 1990-08-02 Boots Co Ltd Verwendung von chinolonen fuer die herstellung eines arzneimittels zur behandlung von herzerkrankungen.
GR850426B (fi) * 1984-02-24 1985-06-18 Lilly Co Eli
US4670445A (en) * 1984-03-05 1987-06-02 Eli Lilly And Company Inotropic agents
US4578387A (en) * 1984-03-05 1986-03-25 Eli Lilly And Company Inotropic agents
DE3576686D1 (de) * 1984-08-15 1990-04-26 Boots Co Ltd Chinolinone, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen praeparate.
DE3446812A1 (de) * 1984-12-21 1986-06-26 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazoderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel
GB8515209D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents
DE3522230A1 (de) * 1985-06-21 1987-01-02 Thomae Gmbh Dr K Neue 2-arylimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
GB8726950D0 (en) * 1987-11-18 1987-12-23 Boots Co Plc Chemical process
GB8804016D0 (en) * 1988-02-22 1988-03-23 Boots Co Plc Therapeutic agents

Also Published As

Publication number Publication date
GB8804016D0 (en) 1988-03-23
IE890293L (en) 1989-08-22
NZ228035A (en) 1990-11-27
EP0330340A1 (en) 1989-08-30
KR900700455A (ko) 1990-08-13
AU3187489A (en) 1989-09-06
US4997840A (en) 1991-03-05
PT89794A (pt) 1989-10-04
NO894187L (no) 1989-10-20
CN1049659A (zh) 1991-03-06
NO894187D0 (no) 1989-10-20
PL277819A1 (en) 1990-01-08
HU891560D0 (en) 1990-02-28
IL89286A0 (en) 1989-09-10
DK497489D0 (da) 1989-10-09
WO1989007593A1 (en) 1989-08-24
ZA89923B (en) 1989-10-25
JPH02503320A (ja) 1990-10-11
DK497489A (da) 1989-11-16
DD283609A5 (de) 1990-10-17

Similar Documents

Publication Publication Date Title
DE68921798T2 (de) Therapeutische Nuleoside.
FI903656A0 (fi) Terapeutiska kinuklidinfoereningar.
FI906367A0 (fi) Terapeutiska nukleosider.
FI913899A0 (fi) Terapeutiska aerosolblandningar.
FI883757A0 (fi) Terapeutiska nukleosider.
FI895509A0 (fi) Terapeutiskt redskap.
DE68907325T2 (de) Massagegerät.
FI894688A (fi) Flytande oralt tagbart terapeutiskt system.
FI890176A0 (fi) Preventivmedel:mikrokondom.
FI881651A (fi) Terapeutiska nukleosider.
FI904854A0 (fi) Terapeutiska nukleosider.
FI902973A0 (fi) Magnetfaeltsgenerator foer terapeutiska aendamaol.
FI875039A0 (fi) Terapeutiska sammansaettningar foer veterinaermedicinsk anvaendning.
FI893897A (fi) Terapeutiska nukleosider.
DE68913289D1 (de) Entseuchungsverfahren.
FI881216A (fi) Terapeutiska nukleosider.
FI894321A0 (fi) Terapeutiska aemnen.
DE68912402T2 (de) Massage-Einheit.
DE68910004T2 (de) Therapeutisches Instrument.
NO901573L (no) Terapeutiske midler.
NO901574L (no) Terapeutiske midler.
FI912852A0 (fi) Terapeutiska dekapeptider.
ATE90865T1 (de) Massagegeraet.
ES1004874Y (es) Vendaje terapeutico mejorado.
ATE100307T1 (de) Massage-einheit.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: THE BOOTS COMPANY PLC